Empowered by Tyler Technologies
Refine Results

The population density of Arizona was 61 in 2018. The population density of Georgia was 179 in 2018.

Population Density

Population Density is computed by dividing the total population by Land Area Per Square Mile.

Above charts are based on data from the U.S. Census American Community Survey | ODN Dataset | API - Notes:

1. ODN datasets and APIs are subject to change and may differ in format from the original source data in order to provide a user-friendly experience on this site.

2. To build your own apps using this data, see the ODN Dataset and API links.

3. If you use this derived data in an app, we ask that you provide a link somewhere in your applications to the Open Data Network with a citation that states: "Data for this application was provided by the Open Data Network" where "Open Data Network" links to http://opendatanetwork.com. Where an application has a region specific module, we ask that you add an additional line that states: "Data about REGIONX was provided by the Open Data Network." where REGIONX is an HREF with a name for a geographical region like "Seattle, WA" and the link points to this page URL, e.g. http://opendatanetwork.com/region/1600000US5363000/Seattle_WA

Geographic and Population Datasets Involving Georgia or Arizona

  • API

    COVID-19 Cases by Zip Code

    citydata.mesaaz.gov | Last Updated 2024-05-22T21:00:13.000Z

    Information reported weekly by the Arizona Department of Health of confirmed COVID-19 cases by zip code and displayed here to better visualize the data. Direct REST Endpoint URL in Source Link field below. Statewide data available at https://www.azdhs.gov/preparedness/epidemiology-disease-control/infectious-disease-epidemiology/covid-19/dashboards/index.php.

  • API

    City of Mesa Population

    citydata.mesaaz.gov | Last Updated 2024-05-16T14:51:19.000Z

    City of Mesa population provided by Census Bureau Population Estimates Program (PEP) updated annually as of July 1. See <b><a href="https://www.census.gov/programs-surveys/popest/data/tables.html?utm_campaign=20240516pio&utm_medium=email&utm_source=govdelivery">Population and Housing Unit Estimates.</b></a> Census PEP estimates are used for state revenue sharing per AZ statute (42-5033.01). <b>This dataset is the authoritative source for all city metrics such as Crimes or Traffic Collisions per 1,000 residents.</b> 2024-2040 population projections provided by Maricopa County Association of Governments (MAG) and adopted June 2023. MAG's planning area and incorporated jurisdiction projections are published at <b><a href="https://azmag.gov/Portals/0/Maps-Data/Population-Housing/MAG-Socioeconomic-Projections-Report-2023.pdf?ver=02iYbZGsxK1mEY4JfIy5ZQ%3d%3d">2023 MAG Socioeconomic Projections</b></a> Other sources of population estimates include US Census American Community Survey 1-year and 5-year Estimates at https://citydata.mesaaz.gov/d/n5gn-m5c3 and https://citydata.mesaaz.gov/Economic-Development/d/9nqf-ygw6, Arizona Office of Economic Opportunity (OEO) at https://www.azcommerce.com/oeo/population/population-estimates/ (see link for OEO methodology which differs slightly from official US Census Estimates) and City of Mesa Office of Economic Development at https://www.selectmesa.com/business-environment/demographics (ESRI Community Analyst).

  • API

    Rates of COVID-19 Cases or Deaths by Age Group and Vaccination Status

    data.cdc.gov | Last Updated 2023-07-20T16:01:58.000Z

    Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022. Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases

  • API

    COVID-19 Deaths by Demographic Grouping

    sharefulton.fultoncountyga.gov | Last Updated 2023-01-30T16:59:04.000Z

    This dataset consists of death rates from COVID-19 among Fulton County residents segmented by race, age and sex. The dataset is derived from data provided by the Georgia Department of Public Health at https://ga-covid19.ondemand.sas.com.

  • API

    Incidence Rate Of Leukemia Per 100,000 All States

    opendata.utah.gov | Last Updated 2019-04-19T00:30:16.000Z

    Incidence Rate Of Leukemia Per 100,000 All States

  • API

    Rates of COVID-19 Cases or Deaths by Age Group and Vaccination Status and Booster Dose

    data.cdc.gov | Last Updated 2023-06-09T00:47:32.000Z

    Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022. Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases

  • API

    DPH Covid Vaccinations: Persons vaccinated by race and county

    sharefulton.fultoncountyga.gov | Last Updated 2024-05-28T11:36:45.000Z

    Persons vaccinated by race and county For a detailed description of the data, see "About Data" on the DPH Vaccine Distribution Dashboard: https://experience.arcgis.com/experience/3d8eea39f5c1443db1743a4cb8948a9c

  • API

    Age Adjusted Incidence Rates Of Bladder Cancer Per 100,000 All States

    opendata.utah.gov | Last Updated 2019-02-11T20:58:05.000Z

    Age Adjusted Incidence Rates Of Bladder Cancer Per 100,000 All States

  • API

    Age Adjusted Incidence Rates Of Bladder Cancer Per 100,000 All States-TEST

    opendata.utah.gov | Last Updated 2014-10-20T15:36:15.000Z

    Age Adjusted Incidence Rates Of Bladder Cancer Per 100,000 All States-TEST

  • API

    FY 2021_NCVAS Population Data For State Summaries

    www.datahub.va.gov | Last Updated 2023-08-25T19:49:04.000Z

    This dataset is comprised of 1-year estimate data from the American Community Survey published as of 2021.